Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis

Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

(2019) Marc Humbert et al.   EUROPEAN RESPIRATORY JOURNAL

Pulmonary Arterial Hypertension: Combination Therapy in Practice

(2018) Marsha Burks et al.   American Journal of Cardiovascular Drugs

Haemodynamics and serial risk assessment in systemic-sclerosis associated pulmonary arterial hypertension

(2018) Jason Weatherald et al.   EUROPEAN RESPIRATORY JOURNAL

Risk-stratified outcomes with initial combination therapy in pulmonary arterial hypertension: Application of the REVEAL risk score

(2018) Adaani E. Frost et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

An overview of the 6th World Symposium on Pulmonary Hypertension

(2018) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Risk stratification and medical therapy of pulmonary arterial hypertension

(2018) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Pulmonary hypertension due to left heart disease

(2018) Jean-Luc Vachiéry et al.   EUROPEAN RESPIRATORY JOURNAL

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension

(2017) David Kylhammar et al.   EUROPEAN HEART JOURNAL

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

(2017) Marius M. Hoeper et al.   EUROPEAN RESPIRATORY JOURNAL

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

(2017) Athénaïs Boucly et al.   EUROPEAN RESPIRATORY JOURNAL

Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension

(2017) Jason Weatherald et al.   CIRCULATION

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

(2016) John Gerry Coghlan et al.   ANNALS OF THE RHEUMATIC DISEASES

Connective tissue disease-related pulmonary arterial hypertension

(2016) Vivek Thakkar et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

World Health Organization Group I Pulmonary Hypertension

(2016) Kurt W. Prins et al.   CARDIOLOGY CLINICS

Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study

(2016) Marius M Hoeper et al.   Lancet Respiratory Medicine

Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension

(2015) Paul M. Hassoun et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)

(2015) Lewis J. Rubin et al.   EUROPEAN RESPIRATORY JOURNAL

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

(2015) Nazzareno Galiè et al.   NEW ENGLAND JOURNAL OF MEDICINE

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)

(2014) Gérald Simonneau et al.   EUROPEAN RESPIRATORY JOURNAL

Performance of the REVEAL pulmonary arterial hypertension prediction model using non-invasive and routinely measured parameters

(2014) Rebecca Cogswell et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

(2013) J Gerry Coghlan et al.   ANNALS OF THE RHEUMATIC DISEASES

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Riociguat for the Treatment of Pulmonary Arterial Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pulmonary arterial hypertension

(2013) David Montani et al.   Orphanet Journal of Rare Diseases

Sex Differences in the Diagnosis, Treatment, and Outcome of Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management

(2011) Shelley Shapiro et al.   CHEST

Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL

(2010) Lorinda Chung et al.   CHEST

Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study

(2009) E. Hachulla et al.   RHEUMATOLOGY